ANA ISABEL
SÁNCHEZ FRUCTUOSO
Profesora titular de universidad
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (16)
2022
-
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study
Clinical transplantation, Vol. 36, Núm. 3, pp. e14550
2021
-
Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study
Clinical Transplantation, Vol. 35, Núm. 5
2020
-
Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study
Clinical Transplantation, Vol. 34, Núm. 1
-
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: A phase 3, randomized clinical trial
Clinical Infectious Diseases, Vol. 70, Núm. 2, pp. 181-190
2019
2016
-
Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation
Transplant International, Vol. 29, Núm. 12, pp. 1317-1328
-
Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study
Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2944-2946
2014
-
Response to circulatory death determination in uncontrolled organ donors: A panel viewpoint
Annals of Emergency Medicine
2013
-
A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation
American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500
2011
-
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients
American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971
-
Erratum: Estimation of renal allograft half-life: Fact or fiction? (Nephrology Dialysis Transplantation (2011) 26 (30133018) DOI 10.1093/ndt/gfq788)
Nephrology Dialysis Transplantation
2010
-
Changes in magnesium and potassium homeostasis after conversion from a calcineurin inhibitor regimen to an mTOR inhibitorbased regimen
Transplantation Proceedings, Vol. 42, Núm. 8, pp. 3047-3049
-
Long-term graft function changes in kidney transplant recipients
NDT Plus, Vol. 3, Núm. SUPPLL. 2
2009
-
A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year
Transplantation, Vol. 88, Núm. 6, pp. 803-809
-
Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results of the MIDATA Study
Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2309-2312
2007
-
Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry
Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159